進化過程としての転移
Samra Turajlic1, Charles Swanton2
1The Francis Crick Institute, 44 Lincoln's Inn Fields, London WC2A 3LY2, UK. Renal and Skin Units, The Royal Marsden Hospital, London SW3 6JJ, UK.
まとめ
転移した癌は ほとんど治癒できませんが 遺伝的進化を理解することで 新しい治療の脆弱性が明らかになります 比較研究によると 染色体不安定などの大きな遺伝子変化が 転移性疾患の発症を促します
科学分野:
- 腫瘍学
- 癌 生物学
- 進化生物学
背景:
- 転移性疾患は癌による死亡の主な原因であり,有効な治療法は限られている.
- 転移したサブクローンは腫瘍の進行中に発生し,治療戦略を複雑にします.
研究 の 目的:
- 原発性腫瘍と転移性腫瘍を比較した研究をレビューする.
- 転移した病気の 遺伝的進化を理解するために
- 転移した癌の潜在的治療的脆弱性を特定する.
主な方法:
- 原発性および転移性腫瘍の比較ゲノム分析
- 癌の進化と転移に関する最近の科学文献のレビュー
主要な成果:
- 転移性疾患の進化には,原発性腫瘍と比較して 異なった遺伝的変化が伴う.
- 染色体不安定性を含むマクロ進化のシフトは転移に関与しています.
- 転移性コロニー化の時間的パターンと経路を理解することは極めて重要です
結論:
- 比較研究により 転移の生物学的な洞察が得られます
- 原発性腫瘍と転移性腫瘍の違いを特定することで,治療の開発を導くことができます.
- 転移の進化を研究する際の課題を克服することは 患者の成果を向上させるための鍵です
さらに関連する動画
関連する概念動画
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis
3.8K
3.8K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
Cancers Originate from Somatic Mutations in a Single Cell
15.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K


